Suchergebnisse - "Martín Dávila, Pilar"

PubPharm (7)

1

Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients : Impact of Empirical Antibiotic Therapy

enthalten in: Microorganisms | 2024

von Royo-Cebrecos, C. | Laporte-Amargós, J. | Peña, M. | +36

2

Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer : Differences between Patients with Hematological Malignancies and Solid Tumors

enthalten in: Pathogens (Basel, Switzerland) | 2022

von Royo-Cebrecos, C. | Laporte-Amargós, J. | Peña, M. | +36

3

Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients : a Matched Control Study (ZENITH Study)

enthalten in: Microbiology spectrum | 2022

von Bergas, A. | Albasanz-Puig, A. | Fernández-Cruz, A. | +32

4

Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia

enthalten in: Microorganisms | 2022

von Albasanz-Puig, A. | Durà-Miralles, X. | Laporte-Amargós, J. | +39

5

Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)

enthalten in: Transplant infectious disease : an official journal of the Transplantation Society | 2021

von Pierrotti, L. | Pérez-Nadales, E. | Fernández-Ruiz, M. | +94

6

Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study) : study protocol of a retrospective multicentre international study

enthalten in: BMJ open | 2019

von Albasanz-Puig, A. | Gudiol, C. | Parody, R. | +77

7

Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia

enthalten in: Antimicrobial agents and chemotherapy | 2017

von Gudiol, C. | Royo-Cebrecos, C. | Abdala, E. | +52

1
[1]